Table 5.
Associations between CISC adherence (I-CAS) and the studied factors
| Evaluated factor | P-value | 95% CI | OR |
|---|---|---|---|
| Age | 0.359a) | -15.48 to 6.00 | |
| PGI-I | 0.535a) | -0.48 to 0.88 | |
| MMS | 0.966a) | -1.91 to 1.99 | |
| USP SUI | 0.868a) | -1.36 to 1.16 | |
| USP OAB | 0.881a) | -2.60 to 3.00 | |
| USP VD* | < 0.001a) | -4.41 to -1.51 | |
| USP total | 0.116a) | -6.47 to 0.75 | |
| HAD* | < 0.001a) | 2.82 to 9.30 | |
| Anxiety subscore | 0.052a) | -0.02 to 4.42 | |
| Depression subscore* | < 0.001a) | 2.21 to 5.51 | |
| CISC duration (months) | 0.079a) | -102.97 to 6.64 | |
| Number of daily CISC* | 0.031a) | -4.19 to -0.24 | |
| Spontaneous micturition/day* | < 0.001a) | 1.05 to 2.75 | |
| InCaSaQ | 0.253a) | -1.52 to 5.37 | |
| EDSS* | 0.024a) | -2.09 to -0.16 | |
| Sex | 0.235b) | 0.42–208.24 | 4.09 |
| Botulinum toxin injection | 0.055b) | 0.86–392.98 | 7.88 |
| Anticholinergic therapy | 1.000b) | 0.21–7.15 | 1.17 |
| Repeated UTI | 0.391b) | 0.01–2.92 | 0.29 |
| Complete urinary retention | 0.113b) | 0.73–336.95 | 6.74 |
| Morphological abnormality | 1.000b) | 0–97.35 | 0.00 |
| ICDQ total | 0.058c) | -0.12 to 7.34 | |
| Item 1i | 0.669c) | -0.4 to 0.61 | |
| Item 1f | 0.357c) | -0.15 to 0.41 | |
| Item 2i* | < 0.001c) | 0.39 to 1.09 | |
| Item 2f* | < 0.001c) | 0.34 to 1.03 | |
| Item 3i* | 0.031c) | 0.03 to 0.58 | |
| Item 3f | 0.057c) | -0.01 to 0.46 | |
| Item 4i | 0.057c) | -0.01 to 0.44 | |
| Item 4f* | 0.042c) | 0.01 to 0.36 | |
| Item 5i | 0.083c) | -0.02 to 0.28 | |
| Item 5f | 0.083c) | -0.02 to 0.29 | |
| Item 6i | 0.162c) | -0.04 to 0.21 | |
| Item 6f | 0.329c) | -0.05 to 0.14 | |
| Item 7i | 0.083c) | -0.02 to 0.29 | |
| Item 7f* | 0.042c) | 0.01 to 0.36 | |
| Item 8i | 0.110c) | -0.08 to 0.71 | |
| Item 8f | 0.110c) | -0.07 to 0.61 | |
| Item 9i | 0.613c) | -0.29 to 0.18 | |
| Item 9f | 0.940c) | -0.26 to 0.24 | |
| Item 10i | 0.658c) | -0.39 to 0.6 | |
| Item 10f | 0.227c) | -0.11 to 0.46 | |
| Item 11i | 0.422c) | -0.94 to 0.43 | |
| Item 11f | 0.628c) | -0.29 to 0.18 | |
| Item 12i | 0.663c) | -0.89 to 0.58 | |
| Item 12f | 0.878c) | -0.52 to 0.45 | |
| Item 13i | 0.664c) | -0.27 to 0.42 | |
| Item 13f | 0.940c) | -0.26 to 0.24 |
CISC, clean intermittent self-catheterization; I-CAS, Intermittent-Catheterization Scale; CI, confidence interval; OR, odds ratio; PGI-I, Patient Global Impression of Improvement; MMSE, Mini-Mental State Examination; USP, Urinary Symptom Profile; SUI, stress urinary incontinence; OAB, overactive bladder; VD, voiding dysfunction; HAD, Hospital Anxiety and Depression scale; InCaSaQ, Intermittent Catheterization Satisfaction Questionnaire; EDSS, Expended Disability Status Scale; UTI, urinary tract infection; ICDQ: Intermittent Catheterization Difficulty Questionnaire.
*
Significant difference.
a)
t-test.
b)
Chi-square test.
c)
Fisher exact test.